Suchergebnisse für WTO

Darf die Nationalbank kryptobasierte Sichtguthaben (wCBDC) ausgeben?

This article examines whether the current monetary law provisions permit the issuance of wholesale central bank digital currency (wCBDC) by the Swiss National Bank. After interpreting the relevant competence provisions, the question can in principle be answered in the affirmative, since wCBDC is not a new, third type of central bank money (in addition to banknotes and traditional sight deposits),…

The New EU Foreign Subsidies Regulation and its Implications for Switzerland

The EU has adopted a new unilateral instrument to control subsidies granted by non-EU countries, such as Switzerland, to companies operating in the EU. This subsidy control combines antitrust, state aid and trade rules, but applies directly to companies rather than to foreign states or granting authorities. Companies with some activities in the EU fall within the scope of this foreign subsidy…

Darf die Nationalbank kryptobasierte Sichtguthaben (wCBDC) ausgeben?

This article examines whether the current monetary law provisions permit the issuance of wholesale central bank digital currency (wCBDC) by the Swiss National Bank. After interpreting the relevant competence provisions, the question can in principle be answered in the affirmative, since wCBDC is not a new, third type of central bank money (in addition to banknotes and traditional sight deposits),…

Förderung der ökologischen und sozialen Verantwortung durch den Bund im öffentlichen Beschaffungswesen und in der Privatwirtschaft

The Federal government has committed itself to setting a good example in the Sustainable Development Strategy 2016–2019 and in the 2030 Agenda. Sustainable development is a constitutional mandate that must also be taken into consideration in public procurement procedures. The pressure from parliamentarians seems to be bearing fruit and accordingly, as part of the total revision of the Swiss…

Europareport

Innerhalb eines Verfahrens der ersten Prüfungsphase (Phase I) hat die Europäische Kommission die Übernahme der Consumer Health-Sparte von Pfizer durch das britische Unternehmen GlaxoSmithKline unter Auflagen genehmigt.